Productivity losses among treated depressed patients relative to healthy controls

J Occup Environ Med. 2010 Feb;52(2):125-30. doi: 10.1097/JOM.0b013e3181ce10a8.

Abstract

Objectives: Estimate the productivity-related cost of depression in an employed population.

Methods: By using administrative data, annual short-term disability (STD) and absenteeism costs ($2005) were compared for patients with depression and treated with antidepressants and for a matched control group without depression.

Results: Mean annual STD costs were $1038 among treated depressed patients versus $325 among controls and $1685 among a subgroup of severely depressed treated patients versus $340 among their controls. After controlling for demographic and employment characteristics, treated patients with depression had STD costs that were $356 higher per patient and those with severe depression had costs that were $861 higher. The marginal impact of treated depression on absenteeism was $377.

Conclusions: Even when depressed patients are treated with antidepressants, there are substantial productivity losses. Therapies that can better manage depression may provide opportunities for savings to employers.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Absenteeism
  • Adult
  • Antidepressive Agents / economics
  • Case-Control Studies
  • Costs and Cost Analysis / economics
  • Costs and Cost Analysis / statistics & numerical data
  • Depressive Disorder / drug therapy
  • Depressive Disorder / economics*
  • Depressive Disorder / psychology
  • Drug Costs / statistics & numerical data
  • Efficiency*
  • Employer Health Costs / statistics & numerical data
  • Female
  • Humans
  • Male
  • Middle Aged
  • Multivariate Analysis
  • United States

Substances

  • Antidepressive Agents